Private equity firm Quadria Group on Tuesday announced the launch of HealthQuad Fund III, with a target corpus of USD 200 million and a USD 100 million in greenshoe option. HealthQuad Fund III succeeds Funds I and II, which have supported over 18 healthcare companies, including Qure.ai, Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences. Quadria Group is aiming to raise USD 300 million (about Rs 2,550 crore) for its HealthQuad Fund III. Quadria Group has retained a large part of the existing investment and investment committee team members, who will continue to be involved in the existing portfolio investments, a company statement said. It will also add more people to its investing, operating and clinical team. "India presents one of the world's most compelling healthcare investment opportunities, driven by growing demand, digital acceleration, and underserved segments across primary, diagnostic, and chronic care. "With the full ownership of Fun
Singapore-based company says it has largest dedicated healthcare PE fund for South and Southeast Asia
In various healthcare companies covering hospitals, pharmaceuticals, life sciences, medical devices, among others
Founded in 2010, NephroPlus currently operates about 450 dialysis centres across three main countries: India, the Philippines, and Uzbekistan
Maxivision offers eye care services to over five million patients in 42 centres across six states in southern and western India
Quadria itself will focus on strategic initiatives and operational improvement in portfolio companies
In an interview, Amit Varma explains what sets his healthcare-focused fund apart from other players in the market